Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients. - Wikidata - awgldk - TriplyDB

Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.

Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.

http://www.wikidata.org/entity/Q34996098

about

Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?Highlight report: Erroneous sample annotation in a high fraction of publicly available genome-wide expression datasets Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.Glucose Promotes a Pro-Oxidant and Pro-Inflammatory Stromal Microenvironment Which Favors Motile Properties in Breast Tumor Cells.EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer.Highlight report: Role of the circadian clock system in breast cancer.The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.Highlight report: The relationship of DNA copy number alterations and mRNA levels in cancer.

P2860

Q28073252-F8B6D51B-6E95-422A-933E-3BF8D3602952 Q34494513-0D729CDE-F604-4B04-B5C3-41C969A50E37 Q36550641-25B09BC9-8028-4CC1-95FA-300A6811A46E Q36561589-08A3056A-8A83-4970-9AC6-3CE27F7C769E Q38758637-A27036B1-BA64-4D61-B436-C8E0C7A71D71 Q42243028-61F533B1-5F46-451F-9E72-91F4407EBA90 Q43208282-9F465EBD-C42B-4F98-952C-1254F1982056 Q47273449-57F2A31C-832A-4004-8617-CBB05A4F9CB2 Q49732669-A998081E-4C2A-47DB-8D3D-8EBAECA14AAE

P2860

Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.

http://www.wikidata.org/entity/Q34996098

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prognostic influence of cycloo ...... gative breast cancer patients.

@ast

Prognostic influence of cycloo ...... gative breast cancer patients.

@en

Prognostic influence of cycloo ...... gative breast cancer patients.

@nl

type

label

Prognostic influence of cycloo ...... gative breast cancer patients.

@ast

Prognostic influence of cycloo ...... gative breast cancer patients.

@en

Prognostic influence of cycloo ...... gative breast cancer patients.

@nl

prefLabel

Prognostic influence of cycloo ...... gative breast cancer patients.

@ast

Prognostic influence of cycloo ...... gative breast cancer patients.

@en

Prognostic influence of cycloo ...... gative breast cancer patients.

@nl

P1433

Q34996098-DE15984A-9D9E-4262-9B02-59AF86BDBA5D

P1476

Q34996098-D846E1A4-9262-409B-AED7-B7A552C61E48

P2093

Q34996098-037019ED-7E1C-42CF-A052-5B63B4A8C2D2

Q34996098-14BFFB23-F09D-42C6-9A1C-92A2C99F7211

Q34996098-24F74281-CEB1-415E-91BD-25E1C8985D56

Q34996098-2FEC8ECE-A161-4FCB-9A27-0681DE1EECF1

Q34996098-4363041B-FE9F-4BD5-826E-09DFCDA3EE4B

Q34996098-5E794982-0DE3-4E25-AB84-38CD3E450318

Q34996098-99AB0301-7310-4D56-A9A3-9C073899FECA

Q34996098-AFD649E1-718A-46CC-A445-819484485ED4

Q34996098-C1671807-59E7-462D-A67A-01317A6ACC10

P2860

Q34996098-044AB66A-231D-4462-9498-818926D4BBEE

Q34996098-0631E04C-05B6-4260-AA26-9CBC1756381E

Q34996098-0D575C01-28A8-4AA4-8D15-898B9152E9FD

Q34996098-0DCCA18E-C23F-40C6-9033-C98802FDD22B

Q34996098-0FB98404-D5D2-4DBF-BCA3-2D0B1A495C77

Q34996098-13CD4493-BF35-4EE8-90CA-DF5D025B12FE

Q34996098-191C4E05-4D51-4B49-A59B-88408CCBEC66

Q34996098-2411A528-52A6-4033-BF65-41734D3D146E

Q34996098-36F8998F-C5C8-4138-9AAA-D87B6A30ED9C

Q34996098-38114C04-5CE7-4067-BE19-496E01AA6FF5

P2888

Q34996098-1779B840-EC2B-43A9-B3D5-73C460955135

P304

Q34996098-868237E9-AE77-4A2D-9418-A00B77C79C9F

P31

Q34996098-52A9A1E0-572C-481F-8AC7-BBA872A328FF

P356

Q34996098-F75929E4-CC4F-4A68-B891-D9787A044F6B

P407

Q34996098-A2C6A5C2-AD17-4CD7-A71B-CC5A3243E296

P478

Q34996098-913F1478-A364-4E26-ACCC-0C9412D0C573

P50

Q34996098-74957D9A-3817-40A2-839B-5DF312E5B91B

P577

Q34996098-AD3ED4A6-360D-464B-ADE1-B941C04F5EC6

P5875

Q34996098-A5A3E906-34E7-4C8C-935F-49F24AC06903

P6179

Q34996098-999F54F9-AA5D-47BD-A059-01B0CAF3F49C

P698

Q34996098-BA70EA01-31F1-4B2A-BC89-D03F4A8DAD35

P932

Q34996098-3918373D-042E-42DF-9B0B-F7B26E3C46B8

P356

1471-2407-14-952

P1433

P1476

Prognostic influence of cycloo ...... gative breast cancer patients.

@en

P2093

Antje Lebrecht

http://www.w3.org/2001/XMLSchema#string

Cristina Cotarelo

http://www.w3.org/2001/XMLSchema#string

Daniel Böhm

http://www.w3.org/2001/XMLSchema#string

Gerald Hoffmann

http://www.w3.org/2001/XMLSchema#string

Isabel Sicking

http://www.w3.org/2001/XMLSchema#string

Karlien Rommens

http://www.w3.org/2001/XMLSchema#string

Marco J Battista

http://www.w3.org/2001/XMLSchema#string

Marcus Schmidt

http://www.w3.org/2001/XMLSchema#string

Susanne Gebhard

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells.

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence

Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.

A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.

P2888

1471-2407-14-952

P304

952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-952

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Jan G Hengstler

P577

2014-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269713253

http://www.w3.org/2001/XMLSchema#string

P6179

1051870177

http://www.w3.org/2001/XMLSchema#string

P698

25511800

http://www.w3.org/2001/XMLSchema#string

P932

4302078

http://www.w3.org/2001/XMLSchema#string